Detalhe da pesquisa
1.
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review.
Alzheimers Res Ther
; 16(1): 93, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38678292
2.
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease.
Alzheimers Res Ther
; 16(1): 34, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355535